E Fund Management Co., Ltd. Xencor Inc Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$18.65 - $26.52 $202,147 - $287,450	10,839 New	10,839 $239,000
Q1 2023 May 11, 2023	BUY	$25.95 - $36.95 $187,177 - $266,520	7,213 New	7,213 $201,000
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $1,526 - $2,011	-62 Reduced 0.78%	7,855 $204,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $106,734 - $156,857	5,407 Added 215.42%	7,917 $217,000
Q1 2021 May 12, 2021	BUY	$40.81 - $53.88 $102,433 - $135,238	2,510 New	2,510 $108,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.